In compliance with current regulations, let us know which audience you belong to:
Espansione
Group
A New Paradigm in Ophthalmology and Beyond
—Why we're here
Helping people, through science.
That’s the privilege we take pride in.
We have the ambition to establish new paradigms in ophthalmology and beyond, driven by our desire to provide our partners and their patients with the best, certified medical technologies.
Since 1981, Espansione Group has delivered the highest standard in the industry—pushed on by expert craftsmanship and family-owned values coupled with a global mindset and aspiration.
Every day, we invest heavily in researching and developing the Espansione Ecosystem of technologies and solutions to achieve our ambition.
—Where we are
Enabling progress through science for the betterment of all isn’t an easy purpose to work towards—yet it’s our north star, the guiding principle of all our actions.
That’s what guided us for over four decades. That’s what moved us to become the one and only company to develop, patent and certify a unique photobiomodulation technology, Light Modulation® LLLT, for use in medical fields such as ophthalmology, dermatology and dentistry.
We’ve done all of this by believing in challenging the status quo, innovating with care and ingenuity, and believing in the power of our people.
↓
—Our reach+results
The success of our technologies and solutions have set a global market standard.
6+
Technology patents
50+
Countries Reached
1100+
Solutions installed
400000+
YEARLY TREATMENTS CARRIED-OUT WITH OUR SOLUTIONS
110%+
YEAR-ON-YEAR INCREASE IN TREATMENTS CARRIED-OUT WITH OUR SOLUTIONS
The scientific community already crowned the efficacy of our tech.
10+
ENDORSING GLOBAL KOLs
4+
TFOS Ambassadors Endorsing the Espansione Ecosystem
40+
SCIENTIFIC PUBLICATIONS ON OUR TECHNOLOGY
2000+
PATIENTS USED AS SAMPLE BY OUR RESEARCH PAPERS, WORLDWIDE
Scientific publications on our technology
> OCULAR SURFACE
DRY EYE DISEASE (MGD, CLD, ...)
35
+
Scientific Papers + Articles
CHALAZION
3
+
Scientific Articles
SJÖGREN’S SYNDROME
2
+
Scientific Paper
BLEPHARITIS
2
+
Scientific Papers
MICROBIOME STABILIZATION & DEMODEX BLEPHARITIS
4
+
Scientific Papers
CATARACT & REFRACTIVE SURGERY
5
+
Scientific Paper
> RETINA
DRY AMD
5
+
Scientific Paper
CSC
2
+
Scientific Paper
—Where we are going
Our ambition isn’t limited to that of becoming the undisputed thought leader in diagnosing and treating ocular surface conditions.
Beyond that, we aim at leveraging our know-how and apply it synergically in other fields beyond ophthalmology.
We have already delivered great degrees of innovation to the fields of ophthalmology and dermatology through our patented technology Light Modulation® Low-level Light Therapy and its seamless integration in the Espansione Ecosystem of solutions.
LM® LLLT has set a new medical standard in painlessly and effectively treating the majority of ocular surface conditions, on top of being extremely effective in its dermatology applications.
—Join Our Team
Do you share our values and passion for innovation?
Discover our opportunities and become a part of our dynamic team. Embrace every challenge and drive innovations that benefit all.
—EVERY DAY, WE COLLABORATE
We take pride in having built great partnerships throughout the years with some of the greatest players in the healthcare industry.
—Our Resonance
Our scientific discoveries and our entrepreneurial successes have been featured in the best outlets worldwide.
